LIVE

CI

Cigna Corporation

CI

NYSE·Healthcare·Medical - Healthcare Plans·Mkt cap $73.3B

$284.25

+2.59%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$239.51 - $323.10

P/E

12.05

Fwd P/E

9.35

Beta

0.30

Div Yield

2.22%

Avg Vol

1.6M

Shares Out

264.5M

Mkt Cap

$73.3B

Price action

Price chart

Down 13.5% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Extensive Provider Network
  • Advanced Healthcare Analytics
  • Comprehensive Service Integration
  • Strong Brand Recognition

Bear Case

1 risk

  • Low volatility (beta 0.3).

Growth

Stable outlook

Medicare Market Expansion

Value

Deep value opportunity - significant discount to Managed Care & Health Insurance peers

Momentum

Stable

+2.6% over 3m

Quality

Thin

Excellent business quality

Dividend

Solid

2.22% yield

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Jul 30, 2026

Q2 26 RECAP

APR 30, 2026

Reported EPS of $7.79 vs $7.60 consensus (+2.5% surprise). Revenue of $68.5B vs $66.3B expected (+3.3%). Beat on both top and bottom lines.

EPS beat +2.5%
Rev beat +3.3%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+2.5%

Next: Jul 30, 2026

Revenue trend · last 8Q

+28%

+14%

+11%

+10%

+10%

+5%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$60.5B

$63.7B

$65.6B

$65.5B

$67.2B

$69.7B

$72.5B

$68.5B

Margins · last 8Q

Gross

9.4%

Operating

3.4%

Profit

2.4%

Wall Street consensus

16 analysts · 56% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

9

56%

Hold

4

25%

Sell

3

19%

Median Price Target

$333.50

+17.3% vs $284.25

Low $302.00
Median $333.50
High $400.00

Latest: Wolfe Research · Jun 16, 2026

9 analysts covering

vs Industry

How CI stacks vs Medical - Healthcare Plans

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.